Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
08/2010
08/25/2010CN101015691B Recombinant phages influenza vaccine
08/25/2010CN101002947B Target medicine used for treating bacteriosis, and its preparing method
08/24/2010USRE41555 Antibody purification
08/24/2010US7781647 plants and plant cells comprising of functional mammalian enzyme providing N-glycan biosynthesis that is normally not present in plants, for example mammalian beta 1,4-galactosyltransferase; glycoprotein processing in transgenic plants used as cost efficient and contamination safe factories
08/24/2010US7781566 Peptides, mimetics and antibodies of erbB, TNF, and IgSF receptors; for preventing, treating, and diagnosing mammalian cancer tumors
08/24/2010US7781565 EphA5 receptor targeting fusion protein; having an appropriate binding characteristic to deliver a drug to a cell or cell population
08/24/2010US7781447 O-methylated rapamycin derivatives for alleviation and inhibition of lymphoproliferative disorders
08/24/2010US7781397 Immunoaffinity purification
08/24/2010US7781393 Methods for inhibiting tumor cell growth
08/24/2010US7780993 Therapeutic transplantation using developing, human or porcine, renal or hepatic, grafts
08/24/2010US7780970 comprising a live Lactobacillus, an enzyme (glycosyl transferase enzyme, fructosyl transferase enzyme or glucan sucrase ) produced by the micro-organism and an exopolysaccharide (EPS) produced by the activity of the enzyme; food
08/24/2010US7780969 genetically engineered T. cruzi wherein the amastigote stage-regulated protein is expressed from a gene involved in energy metabolism; suitable for use in diagnosis of Chagas disease, in drug development, in antibody production, and in the production of vaccines, including live vaccines
08/24/2010US7780968 Clostridial toxin derivatives and methods for treating pain
08/24/2010US7780967 Reduced toxicity Clostridial toxin pharmaceutical compositions
08/24/2010US7780966 Artificial invaplex
08/24/2010US7780965 relates to osteopontin (Eta-1) polypeptides ; for enhancing an immune response in an animal; for therapy and prophylaxis of infectious diseases or cancer; immunization
08/24/2010US7780964 Immunoglobulins which bind NOGO
08/24/2010US7780963 A beta -derived diffusible ligands (ADDL) specific immunoglobulin for use in prevention and treatment of alzheimer's diseases
08/24/2010US7780962 Insertion of viruse genes into cells; administering interferon sensitivity Rna virus; antitumor agents, anticancer agents
08/24/2010US7780959 Feline granulocyte macrophage colony stimulating factor nucleic acid molecules
08/24/2010US7780951 Vaccines for immunization against Helicobacter
08/24/2010US7780882 Complexing antigen and liposome; anticancer agents
08/24/2010CA2507749C Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
08/24/2010CA2385655C Dna immunization against chlamydia infection
08/24/2010CA2273821C Detection and modulation of the iaps and naip for the diagnosis and treatment of proliferative disease
08/24/2010CA2181924C Diagnosis and treatment of infections due to streptococci and enterococci
08/24/2010CA2172509C Methods and compositions for microencapsulation of antigens for use as vaccines
08/19/2010WO2010094011A1 Compositions and methods for improved livestock and aquaculture performance
08/19/2010WO2010093993A2 Use of b lymphocyte stimulator protein antagonists to promote transplantation tolerance
08/19/2010WO2010093776A1 Antibiotic therapy to reduce the likelihood of developing post-infectious irritable bowel syndrome
08/19/2010WO2010093706A2 Chemically programmed vaccination
08/19/2010WO2010093606A1 Reciprocal serum/plasma exchange for the treatment of cancer
08/19/2010WO2010093537A2 Influenza hemagglutinin and neuraminidase variants
08/19/2010WO2010093467A1 Methods for inducing transplantation tolerance
08/19/2010WO2010093395A1 Immunoconjugates with an intracellularly-cleavable linkage
08/19/2010WO2010093335A1 Antibodies for diagnosis and treatment of flaviviral infections
08/19/2010WO2010093055A1 Anti-mst1r antibodies and uses thereof
08/19/2010WO2010092963A1 Drug transporter, and adjuvant and vaccine each utilizing same
08/19/2010WO2010092479A2 Influenza vaccines with reduced amounts of squalene
08/19/2010WO2010092477A1 Influenza vaccines with increased amounts of h3 antigen
08/19/2010WO2010092476A1 Influenza vaccine regimens for pandemic-associated strains
08/19/2010WO2010092185A2 Scramblase/cd4 interaction inhibitors for the treatment of lentivirus infections
08/19/2010WO2010092176A2 Nontypable haemophilus influenzae antigens
08/19/2010WO2010091637A1 Antibodies and methods for treating estrogen receptor-associated diseases
08/19/2010WO2010070453A3 Meningococcal vaccines including hemoglobin receptor
08/19/2010WO2010054397A3 N-cadherin: target for cancer diagnosis and therapy
08/19/2010WO2010045598A3 Psma binding ligand-linker conjugates and methods for using
08/19/2010WO2010040572A3 Antibodies against h5n1 influenza viruses
08/19/2010WO2010040033A4 Methods and compositions for modulating an immune response with immunogenic oligonucleotides
08/19/2010WO2010025369A3 Uses of il-22, il-17, and il-1 family cytokines in autoimmune diseases
08/19/2010WO2010022293A3 Methods of processing compositions containing microparticles
08/19/2010WO2010009346A8 Hiv vaccine based on targeting maximized gag and nef to dendritic cells
08/19/2010WO2009156405A9 Novel immunoadjuvant flagellin-based compounds and use thereof
08/19/2010WO2009109908A8 Methods of treating inflammatory pain
08/19/2010US20100212037 Mia-2 protein
08/19/2010US20100210714 Her-2/neu DNA Vaccine Having Anti-Cancer Activity
08/19/2010US20100210004 Plasmodium axenic liver stages as a noninfectious whole organism malaria vaccine
08/19/2010US20100209905 Protein d - an igd-binding protein of haemophilus influenzae
08/19/2010US20100209904 Antibodies for oncogenic strains of HPV and methods of their use
08/19/2010US20100209541 Buccal, polar and non-polar spray or capsule containing drugs for treating metabolic disorders
08/19/2010US20100209516 Triggered Drug Release Via Physiologically Responsive Polymers
08/19/2010US20100209490 Immunoliposome inducing apoptosis into cell expressing death domain-containing receptor
08/19/2010US20100209471 Medical devices having polymeric nanoporous coatings for controlled therapeutic agent delivery and a nonpolymeric macroporous protective layer
08/19/2010US20100209467 Tdf-related compounds and analogs thereof, analogs and bioactive fragments
08/19/2010US20100209457 Pneumococcal serotype 6d
08/19/2010US20100209456 Treating neoplasms with neurotoxin
08/19/2010US20100209455 Thermal inactivation of rotavirus
08/19/2010US20100209454 Attenuated viruses useful for vaccines
08/19/2010US20100209453 Circovirus sequence associated with piglet weight loss disease (pwd)
08/19/2010US20100209452 Compositions comprising an antigen, an amphipathic compound and a hydrophobic carrier, and uses thereof
08/19/2010US20100209451 Compositions and Methods Related to Adenovirus Based Delivery of Antigens
08/19/2010US20100209450 Vaccine comprising streptococcus pneumoniae capsular polysaccharide conjugates
08/19/2010US20100209449 Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
08/19/2010US20100209448 Synthetic anti-candida albicans oligosaccharide based vaccines
08/19/2010US20100209447 Methods of making and using a cell penetrating peptide for enhanced delivery of nucleic acids, proteins, drugs, and adenovirus to tissues and cells, and compositions and kits
08/19/2010US20100209446 Ostertagia Vaccine
08/19/2010US20100209445 Mutant double cyclized receptor peptides inhibiting beta1-adrenoceptor antibodies
08/19/2010US20100209444 MAGE3 Polypeptides
08/19/2010US20100209443 Vaccine for the Prevention of Breast Cancer Relapse
08/19/2010US20100209442 Deglycosylated and desialidated long pentraxin ptx3
08/19/2010US20100209441 Drug for suppressing pathogen occurring in vivo
08/19/2010US20100209440 Targeted Delivery of siRNA
08/19/2010US20100209439 Anti-Prominin-1 Antibody having ADCC Activity or CDC Activity
08/19/2010US20100209438 OVR110 Antibody Compositions and Methods of Use
08/19/2010US20100209437 Anti-CD3 Antibody Fromulations
08/19/2010US20100209436 Method for treating diseases related to mitochondrial dysfunction
08/19/2010US20100209435 Human Anti-OPGL Neutralizing Antibodies As Selective OPGL Pathway Inhibitors
08/19/2010US20100209434 Antibody formulation
08/19/2010US20100209433 Methods for the diagnosis and for the treatment of critically ill patients with endothelin, endothelin agonists and adrenomedullin antagonists
08/19/2010US20100209432 Monoclonal antibodies against glypican-3
08/19/2010US20100209431 Metal triangulo compound and methods of using the same
08/19/2010US20100209430 Method for treating erectile dysfunction
08/19/2010US20100209429 Peptides and methods for the treatment of gliomas and other cancers
08/19/2010US20100209428 ANTIBODY TARGETING OSTEOCLAST-RELATED PROTEIN Siglec-15
08/19/2010US20100209427 Lysine acetylation sites
08/19/2010US20100209426 Inhibitors of progastrin-induced repression of icat for treating and/or preventing colorectal cancer, adenomatous polyposis or metastasis displaying progastrin-secreting cells and cells in which the beta-catenin/tcf-mediated transcriptional pathway is constitutively active
08/19/2010US20100209425 Blood-Brain Barrier Targeting Anti-bodies
08/19/2010US20100209424 Antibodies and fc fusion protein modifications with enhanced persistence or pharmacokinetic stability in vivo and methods of use thereof
08/19/2010US20100209423 Contain an Fc part derived from human origin and do not bind complement factor C1q; for inflammatory and thrombotic disorders such as critical limb ischemia or peripheral arterial occlusive disease; atherosclerosis, thrombosis, restenosis, asthma, arthritis
08/19/2010US20100209422 Antibodies specific for the protofibril form of beta-amyloid protein
1 ... 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 ... 1823